Academic Journal

Advances of Recombinant Adenoviral Vectors in Preclinical and Clinical Applications.

Bibliographic Details
Title: Advances of Recombinant Adenoviral Vectors in Preclinical and Clinical Applications.
Authors: Scarsella, Luca, Ehrke-Schulz, Eric, Paulussen, Michael, Thal, Serge C., Ehrhardt, Anja, Aydin, Malik
Source: Viruses (1999-4915); Mar024, Vol. 16 Issue 3, p377, 18p
Abstract: Adenoviruses (Ad) have the potential to induce severe infections in vulnerable patient groups. Therefore, understanding Ad biology and antiviral processes is important to comprehend the signaling cascades during an infection and to initiate appropriate diagnostic and therapeutic interventions. In addition, Ad vector-based vaccines have revealed significant potential in generating robust immune protection and recombinant Ad vectors facilitate efficient gene transfer to treat genetic diseases and are used as oncolytic viruses to treat cancer. Continuous improvements in gene delivery capacity, coupled with advancements in production methods, have enabled widespread application in cancer therapy, vaccine development, and gene therapy on a large scale. This review provides a comprehensive overview of the virus biology, and several aspects of recombinant Ad vectors, as well as the development of Ad vector, are discussed. Moreover, we focus on those Ads that were used in preclinical and clinical applications including regenerative medicine, vaccine development, genome engineering, treatment of genetic diseases, and virotherapy in tumor treatment. [ABSTRACT FROM AUTHOR]
Subject Terms: GENOME editing, CLINICAL medicine, GENE therapy, VACCINE development, GENETIC transformation
Copyright of Viruses (1999-4915) is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
ISSN: 19994915
DOI: 10.3390/v16030377
Database: Complementary Index